The Joint Corp.

NASDAQ:JYNT

Medical - Care Facilities

Healthcare
$6.65 +1.86%

+$0.17 today

Market cap
$91.03M
Beta
1.10
P/E (TTM)
40.7
EPS (TTM)
$0.23
52W Low $7.50High $13.00

Volume 0.05M

Average 0.07M

JYNT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

The Joint Corp.NASDAQ: JYNT

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 79.0%

Gross margin was 79.0% in Q1 FY2026, up 1.7 pp from a year earlier. On a trailing-twelve-month basis it was 79.9%, up 46.7 pp year over year. Over 3 fiscal years it narrowed by 11.4 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
79.0%-2.5 pp QoQ
Last fiscal yearDec 2025
79.6%+1.6 pp YoY
LTMMar 2026
79.9%+46.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.7 pp——
1 year+1.6 pp——
3 years-11.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
79.6%
Year-over-year change
+1.6pp

Gross Margin vs competitors

How JYNT compares with its peers on the latest reported figures

  • JYNT's LTM Mar 2026 gross margin of 79.9% is the highest of the 9 companies compared; the peer median is 21.0%.
  • Its year-over-year change of +46.7 pp is the highest of 8, against a peer median of -4.5 pp.
  • Over three fiscal years its change of -11.4 pp compares with a peer median of +2.8 pp.
JYNT Competitors Peer median
Gross Margin for JYNT and competitors
Company Period LTM level YoY 3-year change
JYNTThe Joint Corp.LTM Mar 202679.9% +46.7 pp-11.4 pp
BTMDbiote Corp.LTM Mar 202668.5% -2.3 pp+2.8 pp
APYXApyx Medical CorporationLTM Mar 202632.3% -19.3 pp-29.4 pp
CCLDCareCloud, Inc.LTM Mar 202631.7% -14.0 pp+7.3 pp
DCGODocGo Inc.LTM Mar 202629.5% -4.5 pp-4.5 pp
RPIDRapid Micro Biosystems, Inc.LTM Mar 202612.4% +6.3 pp+72.5 pp
LUCDLucid Diagnostics Inc.LTM Mar 2026-40.0% +27.6 pp+798.4 pp
STSSSkyAI, Inc.LTM Mar 2026-106.6% ——
SERASera Prognostics, Inc.LTM Mar 2026-191.2% -199.9 pp-130.5 pp
IKTInhibikase Therapeutics, Inc.FY2025— ——
CGTXCognition Therapeutics, Inc.FY2025— ——
Peer median (excluding JYNT) 21.0%-4.5 pp+2.8 pp

Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue80.01M101.25M46.98M52.16M54.9M
Cost of Revenue7.67M9.17M10.48M11.52M11.23M
Gross Profit72.35M92.08M36.5M40.65M43.67M
Gross Margin90.4%90.9%77.7%77.9%79.6%
Research & Development00000
Selling, General & Admin62.27M81.95M34.92M41.1M42.93M
Operating Expenses66.22M91.25M36.18M42.54M44.58M
Depreciation & Amortization3.92M6.65M8.58M4.72M1.71M
EBITDA10.07M7.89M8.88M2.9M1.48M
EBITDA Margin12.6%7.8%18.9%5.6%2.7%
Operating Income6.13M828.25K318.3K(1.89M)(905.48K)
Operating Margin7.7%0.8%0.7%-3.6%-1.6%
Interest Income0133.1K0280.29K0
Interest Expense0953.53K64.29K00
Other Income / Expenses(69.88K)(133.1K)(64.29K)280.29K675.97K
Income Before Tax6.06M695.15K254.01K(1.61M)(229.5K)
Pre-Tax Margin7.6%0.7%0.5%-3.1%-0.4%
Income Tax Expense(1.51M)68.45K11.02M5.61K38.65K
Net Income7.57M626.71K(9.75M)(5.8M)2.91M
Net Margin9.5%0.6%-20.8%-11.1%5.3%
EPS (Basic)0.460.04(0.66)(0.39)0.19
EPS (Diluted)0.440.04(0.66)(0.39)0.19
Weighted Avg Shares14.32M14.49M14.69M14.92M15.13M
Weighted Avg Shares (Diluted)14.94M14.87M14.69M15.15M15.13M

The Joint Corp.

NASDAQ:JYNT

Intrinsic Alpha fair value

Locked

Current Price

$6.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.